HemoTreat

Manufacturer: Global Treat srl
Effective date: 2021-05-27
Label type: HUMAN OTC DRUG LABEL
Version: 10
Source: full-release
Hydrated at: 2026-05-31 23:40:36

Label at a glance#

ProductHemoTreat

Active ingredientPETROLATUM, LANOLIN, FAT, HARD, CAMPHOR (SYNTHETIC)

Label structure13 sections

Indications and uses

helps relieve itching and discomfort associated with hemorrhoids and anorectal disorders temporarily relieves pain associated with anorectal inflammation and inflamed hemorrhoidal tissues may provide cooling sensation

Dosage and administration

Adults when practical, cleanse the affected area with mild soap and warm water gently dry by patting or blotting with toilet tissue or a soft cloth before application of ointment with the help of the index finger, apply a thin layer of ointment apply 2 times a day, morning and evening, for 5-7 days. Spread on to the affected area, generally on the exterior of the anus and in the vicinity of the anal orifice Childr...

Storage and handling

store at 15-25°C (59-77°F) protect from excessive moisture keep away from direct sunlight

Contacts and useful links#

PhonePoison Help1 (800) 222-1222

PhoneLabel contact1 (800) 580-2238

Websitewww.hemotreat.com

www.hemotreat.com

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

White Petrolatum 21.3% wt/wt

Lanolin 21.25% wtwt

Hard Fat 42.6% wt/wt

Camphor 2.5% wt/wt

Purposes

OTC - PURPOSE SECTION

Protectant

Analgesic

Uses

INDICATIONS & USAGE SECTION

helps relieve itching and discomfort associated with hemorrhoids and anorectal disorders
temporarily relieves pain associated with anorectal inflammation and inflamed hemorrhoidal tissues
may provide cooling sensation

Warnings

WARNINGS SECTION

For rectal use only

OTC - DO NOT USE SECTION

Do not use for more than 30 days
When using this product do not exceed the recommended daily dosage, unless directed by a doctor

Stop use and ask a doctor if:

OTC - STOP USE SECTION

bleeding occurs
condition worsens or does not improve within seven days
signs of a local infection appear
Certain person can develop allergic reactions to ingredients in this product. If the symptom being treated does not subside of if redness, irritation, swelling, pain, and or other symptoms develop or increase, discontinue use and consult a doctor.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children. If swallowed, get medical help or contact a poison Control Center right away 1 (800) 222-1222.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults

when practical, cleanse the affected area with mild soap and warm water
gently dry by patting or blotting with toilet tissue or a soft cloth before application of ointment
with the help of the index finger, apply a thin layer of ointment
apply 2 times a day, morning and evening, for 5-7 days. Spread on to the affected area, generally on the exterior of the anus and in the vicinity of the anal orifice

Children under 12 years

consult a doctor

Other Information

STORAGE AND HANDLING SECTION

store at 15-25°C (59-77°F)
protect from excessive moisture
keep away from direct sunlight

Inactive Ingredients

INACTIVE INGREDIENT SECTION

butylated hydroxyl anisole, calcium carbonate, ethanol, ethylparaben, eucalyptus oil, methylparaben, phenoxyethanol

OTC - QUESTIONS SECTION

Manufactured by SC Global Treat SRL

157 Portului Street, 800211, Galati, Romania

Web: www.hemotreat.com

EMail: contact@hemotreat.com

Questions? Call: 1 (800) 580-2238

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 69758-322-55

HemoTreat

Hemorrhoidal Ointment

50 ml

Product Label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69758-322-55	2023-01-30	C162847	48780-1	f386c64a-3e15-0266-e053-dadaa90a7c1a	HemoTreat (69758-322)
69758-322-71	2023-01-30	C162847	48780-1	f386c64a-3e15-0266-e053-dadaa90a7c1a	HemoTreat (69758-322)

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69758-322	HEMOTREAT (WHITE PETROLATUM, LANOLIN, HARD FAT, CAMPHOR) CREAM [GLOBAL TREAT SRL]	10	Legacy NDC	20210528_fac33481-2983-405f-974d-99e39d1b28e2.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CAMPHOR (SYNTHETIC)	ACTIVE INGREDIENT	5TJD82A1ET	3
FAT, HARD	ACTIVE INGREDIENT	8334LX7S21	3
LANOLIN	ACTIVE INGREDIENT	7EV65EAW6H	3
PETROLATUM	ACTIVE INGREDIENT	4T6H12BN9U	3
CAMPHOR (SYNTHETIC)	ACTIVE MOIETY	5TJD82A1ET	3
FAT, HARD	ACTIVE MOIETY	8334LX7S21	3
LANOLIN	ACTIVE MOIETY	7EV65EAW6H	3
PETROLATUM	ACTIVE MOIETY	4T6H12BN9U	3
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	3
BUTYLATED HYDROXYANISOLE	INACTIVE INGREDIENT	REK4960K2U	3
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	3
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	3
EUCALYPTUS OIL	INACTIVE INGREDIENT	2R04ONI662	3
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	3
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

HemoTreat
white petrolatum, lanolin, hard fat, camphor
BUTYLATED HYDROXYANISOLE
CALCIUM CARBONATE
ALCOHOL
ETHYLPARABEN
EUCALYPTUS OIL
METHYLPARABEN
PHENOXYETHANOL
PETROLATUM
LANOLIN
FAT, HARD
CAMPHOR (SYNTHETIC)

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
69758-322	69758-322-55, 69758-322-71

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BUTYLATED HYDROXYANISOLE	REK4960K2U	IACT
CALCIUM CARBONATE	H0G9379FGK	IACT
ALCOHOL	3K9958V90M	IACT
ETHYLPARABEN	14255EXE39	IACT
EUCALYPTUS OIL	2R04ONI662	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
PETROLATUM	4T6H12BN9U	ACTIB
LANOLIN	7EV65EAW6H	ACTIB
FAT, HARD	8334LX7S21	ACTIB
CAMPHOR (SYNTHETIC)	5TJD82A1ET	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 188 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
ALCOHOL	ALCOHOL	3K9958V90M	PASTE / DENTAL	1.8 %w/w		Exact identifier — unii candidate 59 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SOLUTION / INTRAVESICAL		7892 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION/ DROPS / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	LIQUID / ORAL		162 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CREAM / VAGINAL	0.03 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CONCENTRATE / ORAL	0.08 mg/1ml		Exact identifier — unii candidate 24 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / ORAL		346 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	LOTION / TOPICAL	25 %w/w		Exact identifier — unii candidate 59 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	POWDER, FOR SOLUTION / TOPICAL	40 %w/w		Exact identifier — unii candidate 59 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, SUSPENSION / INTRAMUSCULAR		1 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IONTOPHORESIS	0.1 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IRRIGATION	2 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
CALCIUM CARBONATE	CALCIUM CARBONATE	H0G9379FGK	TABLET, COATED / ORAL	64.8 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	INJECTION, SOLUTION / INTRAVENOUS		6405 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / RESPIRATORY (INHALATION)	0.03 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	TABLET / ORAL	1.8 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	LOTION / TOPICAL		351 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM / TOPICAL		57 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	INJECTION, EMULSION / INTRAVENOUS		520 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SUSPENSION / RECTAL	0.35 %v/v		Exact identifier — unii candidate 59 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	AEROSOL, METERED / RESPIRATORY (INHALATION)		26664 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	POWDER, FOR SOLUTION / ORAL		126 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	INJECTION / INTRAVENOUS	92 %w/v		Exact identifier — unii candidate 59 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	SOLUTION / ORAL		5 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SHAMPOO / TOPICAL		714 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	CONCENTRATE / ORAL	198 mg		Exact identifier — unii candidate 59 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SUSPENSION / ORAL		8 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRAVENOUS		95 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO, SUSPENSION / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	INJECTION, SOLUTION / INTRAMUSCULAR		1000 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / EPIDURAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	SUPPOSITORY / RECTAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 79 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SPRAY / TRANSDERMAL	90 %w/v		Exact identifier — unii candidate 59 equally ranked IID candidates
CALCIUM CARBONATE	CALCIUM CARBONATE	H0G9379FGK	TABLET / ORAL		793 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GEL / VAGINAL		8 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL, FOAM / TOPICAL		72 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GEL / TOPICAL		24 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	OINTMENT / TOPICAL		29 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CREAM / TOPICAL		3000 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CAPSULE, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	GEL / TOPICAL		9971 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	GRANULE, FOR SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SOLUTION, CONCENTRATE / ORAL	150.68 mg/1ml		Exact identifier — unii candidate 59 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	MOUTHWASH / BUCCAL	200 mg/1ml		Exact identifier — unii candidate 59 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	ENEMA / RECTAL	0.18 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	AEROSOL / TOPICAL		561 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
CALCIUM CARBONATE	CALCIUM CARBONATE	H0G9379FGK	CAPSULE, EXTENDED RELEASE / ORAL	4 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / INTRAVENOUS	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
CALCIUM CARBONATE	CALCIUM CARBONATE	H0G9379FGK	TABLET, EXTENDED RELEASE / ORAL	229.7 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
EUCALYPTUS OIL	EUCALYPTUS OIL	2R04ONI662	SYRUP / ORAL	NA		Exact identifier — unii candidate
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / INTRAMUSCULAR	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	FILM, SOLUBLE / BUCCAL		3 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / SUBCUTANEOUS	0.16 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SOLUTION, CONCENTRATE / INTRAVENOUS		4000 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, SOLUTION / INTRAVENOUS		45 mg	Exact identifier — unii candidate 79 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
c35155b4-d20d-441c-e053-2a95a90a1bf5			fac33481-2983-405f-974d-99e39d1b28e2	2021-05-27	Warnings	Exact identifier spl id: c35155b4-d20d-441c-e053-2a95a90a1bf5 spl set id: fac33481-2983-405f-974d-99e39d1b28e2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.